The effect of <i>APOE</i> genotype in real‐world clinical settings: results from the IDEAS and ANGI studies
These findings are particularly important for real-world clinical settings, where genetic risk stratification can inform prevention strategies and treatment decisions. Incorporating genetic information into care, including sex-specific risk assessments, allows for more tailored and personalized interventions, potentially leading to improved clinical outcomes.
Authors
- Ale Castruita
- Caroline Jonson (ORCID: https://orcid.org/0000-0001-7049-6281)
- Renaud La Joie (ORCID: https://orcid.org/0000-0003-2581-8100)
- Daniel R. Schonhaut
- J. Yokoyama
- Alexis P. Oddi (ORCID: https://orcid.org/0000-0001-9151-889X)
- Andrew March
- Ganna Blazhenets (ORCID: https://orcid.org/0000-0003-2419-7373)
- Stefania Pezzoli (ORCID: https://orcid.org/0000-0002-2429-7334)
- Lucy Hanna (ORCID: https://orcid.org/0000-0003-3298-0771)
- Jhony Alejandro Mejía‐Perez
- Kaitlin B Casaletto
- Maria C. Carrillo
- Gil D. Rabinovici
- Constantine Gatsonis
- Tatiana M. Foroud
Institutions
- American College of Radiology (US)
- Alzheimer's Association (US)
- University of California, San Francisco (US)
- Brown University (US)
- University Memory and Aging Center (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_097760
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00